DeborahMarieStephensDO

PubMed

• 1 citations
  Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
  Barr, P. M., Barr, P. M., Barr, P. M., Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Na...> ;Blood. 2024 Apr 18
• Risk Factors for Fragility Fractures in Chronic Lymphocytic Leukemia.
  Lloyd Petty, Deborah Stephens, Anu Sharma> ;Cureus. 2024 Feb 1
• T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
  Vardell, V., Fitzgerald, L., Shah, H., Ermann, D., Hu, B., Stephens, D.> ;American Journal of Hematology. 2024 Mar 1
• 2 citations
  First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma.
  Jennifer A Woyach, Ian W Flinn, Seema A Bhat, Ronald E Savage, Feng Chai, Sudharshan Eathiraj, Sean D Reiff, Elizabeth M Muhowski, Lindsey Granlund, Lyndsey Szuszkiewi...> ;Cancer Discovery. 2024 Jan 12
• A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data.
  Qiao, Y., Huang, X., Moos, P., Ahmann, J., Pomicter, A., Marth, G., Deininger, M., Byrd, J., Woyach, J., Stephens, D.> ;Genome Research. 2024 Feb 7
• Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...
  Barr, P. M., Barr, P. M., Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K Link, Me...> ;Journal of Hematology & Oncology. 2023 Dec 16
• 2 citations
  Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
  Reem Karmali, Jeremy S Abramson, Shuo Ma, Juehua Gao, Adam M Petrich, Deborah M Stephens, Jeffrey Barnes, Jane N Winter, Jason Kaplan, Ephraim Hochberg, Tak Takvorian,...> ;Blood Advances. 2023 Dec 12
• Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
  Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M Stephens, Catherine J Lee, Thomas Ollila, Geoffrey Shouse, Alexey V Danilov, Ke...> ;Journal of Hematology & Oncology. 2023 Nov 9
• 5 citations
  Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.
  Chaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, Deborah M Stephens, Catherine Lai, Catherine M Broome, Susan O'Brien, Haiying Zhu, Kerry J Laing, Allison M Winter, G...> ;Blood Advances. 2023 Sep 12
• Infectious complications among patients receiving ibrutinib for the treatment of hematological malignancies.
  Kenneth Tham, Stacy Prelewicz, Sara deHoll, Deborah M Stephens, Carlos A Gomez> ;American Journal of Health-System Pharmacy. 2024 Feb 8
• Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
  Sonja I Berndt, Joseph Vijai, Yolanda Benavente, Nicola J Camp, Alexandra Nieters, Zhaoming Wang, Karin E Smedby, Geffen Kleinstern, Henrik Hjalgrim, Caroline Besson, ...> ;Leukemia. 2023 Oct 1
• 5 citations
  Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
  Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali K Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J V...> ;Blood Advances. 2023 Aug 22
• 10 citations
  Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
  Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
• 17 citations
  Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
  Tanya Siddiqi, David G Maloney, Saad S Kenderian, Danielle M Brander, Kathleen Dorritie, Jacob Soumerai, Peter A Riedell, Nirav N Shah, Rajneesh Nath, Bita Fakhri, Deb...> ;Lancet. 2023 Aug 19
• 4 citations
  The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
  Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, Amy J Davidoff, Scott F Huntington, Omer Jamy, Gregory Calip, Harsh Shah, Deborah M Stephens, Rebecca Miksad, Ravi B Parik...> ;JAMA Network Open. 2023 Jun 1
• 1 citations
  Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions.
  James Abbott, Jessica Corean, Ashley M Snyder, Scott R Florell, Rodney Miles, Deborah Stephens, David A Wada> ;Skin Health and Disease. 2023 Jun 1
• 5 citations
  Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.
  Victoria A Vardell, Daniel A Ermann, Lindsey A Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens> ;American Journal of Hematology. 2023 Jul 1
• 3 citations
  Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
  Matthew W Parsons, Calvin Rock, Jonathan J Chipman, Harsh R Shah, Boyu Hu, Deborah M Stephens, Randa Tao, Jonathan D Tward, David K Gaffney> ;Cancer Medicine. 2023 Feb 1
• 1 citations
  Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era.
  Jordan B Fenlon, Ryan J Hutten, Skyler B Johnson, Boyu Hu, Harsh Shah, Deborah M Stephens, Amit Maity, David K Gaffney, Randa Tao> ;Leukemia & Lymphoma. 2023 Feb 1
• 1 citations
  Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001.
  Deborah M Stephens, Hongli Li, Louis S Constine, Thomas J Fitzgerald, John P Leonard, Brad S Kahl, Joo Y Song, Michael L LeBlanc, Sonali M Smith, Daniel O Persky, Jona...> ;Haematologica. 2022 Nov 1
• 4 citations
  Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
  Sonja I Berndt, Joseph Vijai, Yolanda Benavente, Nicola J Camp, Alexandra Nieters, Zhaoming Wang, Karin E Smedby, Geffen Kleinstern, Henrik Hjalgrim, Caroline Besson, ...> ;Leukemia. 2022 Dec 1
• 5 citations
  Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients.
  Gage S Black, Xiaomeng Huang, Yi Qiao, Szabolcs Tarapcsak, Kerry A Rogers, Shrilekha Misra, John C Byrd, Gabor T Marth, Deborah M Stephens, Jennifer A Woyach> ;Blood. 2022 Jul 28
• 1 citations
  Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy.
  Calvin B Rock, Jonathan J Chipman, Matthew W Parsons, Chris R Weil, Ryan J Hutten, Randa Tao, Jonathan D Tward, Harsh R Shah, Boyu Hu, Deborah M Stephens, David K Gaffney> ;Advances in Radiation Oncology. 2022 Jul 26
• 6 citations
  Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
  Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, Seongho Kim, Krish Patel, Nancy L Bartlett, Mary-Kate Malecek, Marcus P Watkins, Kami J Maddocks, David A Bond,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
• 13 citations
  Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
  Deborah M Stephens, Ying Huang, Amy S Ruppert, Janek S Walker, Daniel Canfield, Casey B Cempre, Qiang Fu, Sharyn Baker, Boyu Hu, Harsh Shah, Renee Vadeboncoeur, Kerry ...> ;Clinical Cancer Research. 2022 Aug 2
• Join now to see all

Lectures

• How I Think, How I Treat - BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond: Therapeutic Selection, Sequencing, and Next Steps 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019